Sign up to save your podcasts
Or
Share Biologic Therapies Approved for the Treatment of Generalized Myasthenia Gravis - Part 1
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Biologic Therapies Approved for the Treatment of Generalized Myasthenia Gravis - Part 1
In the first episode of a two-part series, Dr. Joseph Conway will discuss four biologic therapies that have been approved in recent years by the FDA for the treatment of adults with generalized myasthenia gravis. In this episode, he will talk about two of the treatment medications: Efgartigimod and Rozanolixizumab.
Show references:
https://doi.org/10.1016/s1474-4422(21)00159-9
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00077-7/abstract
View all episodes
By American Academy of Neurology
4.8
129129 ratings
In the first episode of a two-part series, Dr. Joseph Conway will discuss four biologic therapies that have been approved in recent years by the FDA for the treatment of adults with generalized myasthenia gravis. In this episode, he will talk about two of the treatment medications: Efgartigimod and Rozanolixizumab.
Show references:
https://doi.org/10.1016/s1474-4422(21)00159-9
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00077-7/abstract
More shows like Neurology Minute
View all
JAMA Clinical Reviews
496 Listeners
Neurology® Podcast
300 Listeners
Practical Neurology Podcast
50 Listeners
Mayo Clinic Talks
290 Listeners
The Curbsiders Internal Medicine Podcast
3,333 Listeners
Emergency Medical Minute
263 Listeners
JAMA Neurology Author Interviews
13 Listeners
Neurology Today in 5
22 Listeners
Annals On Call Podcast
195 Listeners
The Clinical Problem Solvers
515 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
364 Listeners
Short Wave
6,411 Listeners
Neurology Exam Prep Podcast
179 Listeners
The Curious Clinicians
369 Listeners
Continuum Audio
79 Listeners